Jie Pan, MD
Neurology · Lubbock, TXNPI 1609369990
Payments from drug & device makers
Across 204 payments — averaging $23.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$685
- AbbVie$501
- UCB, Inc.$356
- Acadia Pharmaceuticals Inc$326
- AstraZeneca$310
- Sanofi$302
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,81099%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 42 | $685 |
| AbbVie | 25 | $501 |
| UCB, Inc. | 11 | $356 |
| Acadia Pharmaceuticals Inc | 13 | $326 |
| AstraZeneca(2 entities) | 7 | $310 |
| Sanofi | 3 | $302 |
| Lilly USA, LLC | 12 | $269 |
| Biogen | 9 | $217 |
| Teva Pharmaceuticals USA, Inc. | 10 | $182 |
| Alnylam Pharmaceuticals Inc. | 8 | $178 |
| MDD US Operations, LLC | 8 | $164 |
| CSL Behring | 5 | $160 |
| EMD Serono, Inc. | 6 | $159 |
| SK Life Science, Inc. | 6 | $126 |
| Lundbeck LLC | 6 | $121 |
| Argenx US, Inc. | 5 | $114 |
| Neurocrine Biosciences, Inc. | 1 | $113 |
| Scilex Pharmaceuticals Inc. | 4 | $82 |
| Johnson & Johnson | 4 | $82 |
| Amneal Pharmaceuticals LLC | 4 | $82 |
| Livanova USA, Inc. | 3 | $64 |
| Genentech USA, Inc. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Abbott | 1 | $24 |
| Amgen | 1 | $23 |
| Pfizer | 1 | $22 |
| Neurelis, Inc. | 1 | $20 |
| Tanabe Pharma America, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$113
How this compares
$4,845 in reported general payments places this provider in the 55th percentile of 1,246 neurology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,544 |
| Memantine Hcl | 141 | $2,713 |
| Donepezil Hcl | 168 | $1,383 |
| Carbamazepine ErCarbamazepine | 14 | $1,112 |
| Levetiracetam | 33 | $1,022 |
| Gabapentin | 81 | $850 |
| Mirtazapine | 37 | $745 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 44 | $596 |
| Nortriptyline Hcl | 65 | $475 |
| Pregabalin | 23 | $465 |
| Propranolol Hcl | 37 | $307 |
| Propranolol Hcl ErPropranolol Hcl | 11 | $275 |
| Topiramate | 24 | $262 |
| Duloxetine Hcl | 14 | $252 |
| Primidone | 28 | $243 |
Paid to pharmacies, not to this prescriber.
Other neurology in Lubbock
- Bhupesh DiheniaLubbock$6.9M
- Mirla AvilaLubbock$1.3M
- Ahmad SabouniLubbock$737K
- Ann BassSan Antonio$12.3M
- Kandasami SenthilkumarBeaumont$7.6M
- Bharathy SundaramSherman$7.2M
- Jamshid LotfiHouston$6M
- Nazanin MajdHouston$5.9M
- Aziz ShaibaniHouston$5.5M
- Elizabeth PeckhamRound Rock$5.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.